About
About Qingdao Haier Biomedical Co., Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; microwave digestion system; UV visible spectrophotometer and total organic carbon analyzer products; and consumables. Further, it provides after-sales services; and U-biobank, U-vaccine, U-reagent, U-blood, and U-laboratory network solutions. The company serves hospitals, bio and pharmaceutical enterprises, universities and colleges, scientific research institutions, centers for disease control, primary public health institutions and blood stations. Qingdao Haier Biomedical Co.,Ltd was founded in 2005 and is based in Qingdao, China.
Research context
Qingdao Haier Biomedical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Qingdao Haier Biomedical Co., Ltd is currently in a long term uptrend where the price is trading 29.9% above its 200 day moving average.
From a valuation standpoint, the stock is 126.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.8.
Qingdao Haier Biomedical Co., Ltd's total revenue rose by 48.0% to $421M since the same quarter in the previous year.
Its net income has increased by 122.7% to $109M since the same quarter in the previous year.
Finally, its free cash flow grew by 246.3% to $253M since the same quarter in the previous year.
Based on the above factors, Qingdao Haier Biomedical Co., Ltd gets an overall score of 4/5.